Abstract
A Phase II Lysa Study of Obinutuzumab Combined with Lenalidomide for Advanced Untretated Follicular B-Cell Lymphoma in Need of Systemic Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have